摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-4-nitro-N-benzoyl-phenylalanine | 69935-12-2

中文名称
——
中文别名
——
英文名称
(S)-4-nitro-N-benzoyl-phenylalanine
英文别名
N-benzoyl-L-(4-nitro)phenylalanine;N-Benzoyl-p-nitro-L-phenylalanin;N-benzoyl-4-nitro-L-phenylalanine;N-Benzoyl-4-nitro-L-phenylalanin;(2S)-2-benzamido-3-(4-nitrophenyl)propanoic acid
(S)-4-nitro-N-benzoyl-phenylalanine化学式
CAS
69935-12-2
化学式
C16H14N2O5
mdl
——
分子量
314.298
InChiKey
VPKNYNJAINDWNE-AWEZNQCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    160-162 °C
  • 沸点:
    619.8±50.0 °C(Predicted)
  • 密度:
    1.364±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    112
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:bb20d3f890215f56e1e376b0830c443e
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-4-nitro-N-benzoyl-phenylalanine溶剂黄146 作用下, 以 二氯甲烷 为溶剂, 以78%的产率得到2-phenyl-4-<(4-nitro)phenylmethyl>-5(4H)-oxazolone
    参考文献:
    名称:
    Peptide-Catalyzed Conversion of Racemic Oxazol-5(4H)-ones into Enantiomerically Enriched α-Amino Acid Derivatives
    摘要:
    We report the development and optimization of a tetrapeptide that catalyzes the methanolytic dynamic kinetic resolution of oxazol-5(4H)-ones (azlactones) with high levels of enantioinduction. Oxazolones possessing benzylic-type substituents were found to perform better than others, providing methyl ester products in 88:12 to 98:2 er. The mechanism of this peptide-catalyzed process was investigated through truncation studies and competition experiments. High-field NOESY analysis was performed to elucidate the solution-phase structure of the peptide, and we present a plausible model for catalysis.
    DOI:
    10.1021/jo402828f
  • 作为产物:
    描述:
    (S)-4-硝基苯基丙氨酸甲酯盐酸盐N,N-二异丙基乙胺 、 lithium hydroxide 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 2.0h, 生成 (S)-4-nitro-N-benzoyl-phenylalanine
    参考文献:
    名称:
    黄病毒蛋白酶的肽-硼酸抑制剂:药物化学和结构生物学
    摘要:
    通过将C末端硼酸部分引入Zika,West Nile和登革热病毒蛋白酶的二肽抑制剂中,可以实现千倍的亲和力提高。所得化合物的K i值在两位数纳摩尔范围内,无细胞毒性,并抑制病毒复制。与西尼罗河病毒蛋白酶的结构活性关系和高分辨率X射线共晶体结构为针对新兴黄病毒病原体的优化共价可逆抑制剂的设计提供了基础。
    DOI:
    10.1021/acs.jmedchem.6b01021
点击查看最新优质反应信息

文献信息

  • Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives
    作者:Bixue Xu、Zhengming Huang、Changxiao Liu、Zegui Cai、Weidong Pan、Peixue Cao、Xiaojiang Hao、Guangyi Liang
    DOI:10.1016/j.bmc.2009.03.003
    日期:2009.4
    A series of derivatives of Matijing-Su (MTS, N-(N-benzoyl-l-phenylalanyl)-O-acetyl-l-phenylalanol) was synthesized and evaluated for their anti-hepatitis B virus (HBV) activities in 2.2.15 cells. The IC50 of compounds 9c (1.40 μM), 9g (2.33 μM) and 9n (2.36 μM), etc. and the selective index of 9n (45.93) of the inhibition on the replication of HBV DNA were higher than those of the positive control
    合成了Matijing-Su的一系列衍生物(MTS,N-(N-(N-苯甲酰基-1-苯丙氨酰基)-O-乙酰基-1-苯基丙醇),并在2.2.15中评估了其抗乙型肝炎病毒(HBV)的活性。细胞。化合物9c(1.40μM),9g(2.33μM)和9n(2.36μM)等的IC 50和9n(45.93)抑制HBV DNA复制的选择性指数高于阳性对照拉米夫定[41.59,(IC 50:82.42μM)]。化合物11d,12a和12e 也表现出显着的抗乙肝病毒活性。
  • Kameda et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1958, vol. 78, p. 767
    作者:Kameda et al.
    DOI:——
    日期:——
  • Synthesis and anti-tumor activity evaluation of Matijin-Su derivatives
    作者:Bixue Xu、Ning Wang、Weidong Pan、Jingying Qiu、Peixue Cao、Meifen Zhu、Yibin Feng、Guangyi Liang
    DOI:10.1016/j.bioorg.2014.05.009
    日期:2014.10
    A series of Matijin-Su (MTS, N-(N-benzoyl-l-phenylalanyl)-O-acetyl-l-phenylalanol) derivatives was synthesized and evaluated for their anti-tumor activities in hepatocellular carcinoma cells. The IC50 of compounds 1, 3, 4, 11, 13 were less than 20μM, and compound 1 and 3 showed an IC50 value of less than 9μM. Expansion inhibition could be found significantly in compound 1 and 3-treated human hepatoma cell HepG2 and PLC/PRF/5, while both compounds exhibit lower toxicity to human hepatocyte cell line L-02. Compound 1 and 3 could induce cell cycle arrest at G1/S phase. This may be attributed to increase level of intracellular reactive oxygen species (ROS). Up-regulation of p38 MAPK activity in responding the ROS stabilize p53 and activate p21 transcription, the critical regulatory in G1/S checkpoint. Observations in this study shed light on the potential of MTS derivatives compound 1 and 3 as novel suppressors to human liver cancer.
  • Unusual amino acids III. Asymmetric synthesis of 3-arylalanines
    作者:Stefan Taudien、Klaus Schinkowski、Hans-Walter Krause
    DOI:10.1016/s0957-4166(00)86017-6
    日期:1993.1
    21 (Z)-alpha-N-benzoylamino-beta-arylacrylic acids and their esters were prepared by known procedures and hydrogenated to the corresponding optically active alpha-benzoyl-beta-arylalanine derivatives with optical yields in the range of 82-95% ee using the cationic rhodium complex of ''PROPRAPHOS'' as the chiral catalyst No electronical influences of the substituents at the aryl moiety on the enantioselectivity were observed but a sterical one, proved by X-ray crystallographic analysis and computer-aided modellings. Deacylation of the hydrogenated spezies produced the hydrochlorides of the 3-arylalanines attended by a partial racemisation In this case the hydrogenation of urethane type protected dehydroaminoacid derivatives seems to be the alternative.
  • Peptide-Catalyzed Conversion of Racemic Oxazol-5(4<i>H</i>)-ones into Enantiomerically Enriched α-Amino Acid Derivatives
    作者:Anthony J. Metrano、Scott J. Miller
    DOI:10.1021/jo402828f
    日期:2014.2.21
    We report the development and optimization of a tetrapeptide that catalyzes the methanolytic dynamic kinetic resolution of oxazol-5(4H)-ones (azlactones) with high levels of enantioinduction. Oxazolones possessing benzylic-type substituents were found to perform better than others, providing methyl ester products in 88:12 to 98:2 er. The mechanism of this peptide-catalyzed process was investigated through truncation studies and competition experiments. High-field NOESY analysis was performed to elucidate the solution-phase structure of the peptide, and we present a plausible model for catalysis.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物